Navigation Links
OBN's 2013 Annual Awards Dinner Celebrates UK Bioscience Success Stories
Date:10/1/2013

.75m collaboration also announced in 2013.

Parsortix, Best Emerging Medtech

Award Presented by Team Consulting

Angle plc spin-out Parsortix has separation technology which captures very rare circulating tumour cells (CTCs) in cancer patient blood. They have launched a research market product but also aim to secure CE Mark approval for the clinical market in 2013, with FDA approval sought during 2014.

Karus Therapeutics, Best Biotech Fundraiser

Award Presented by Akesios Associates

Karus raised £5m as the first tranche of a Series B investment in September 2012 from top tier investors SV Life Sciences (UK and International), New Leaf Venture Partners (US), Novo A/S (Denmark), IP Group (UK), Esperante Ventures (Netherlands) and a number of Angel investors. This award recognizes the progression the company has made in securing this fundraising from this syndicate.

Glide Pharma, Best Medtech Fundraiser

Award Presented by Milton Park

Glide Pharma raised £14m in Feb 2013 from Invesco Perpetual and existing investors.  This will enable the scale-up of manufacturing for its Glide SDI injector system (both drug and device).  Glide won an additional £2.3m of project funding from TSB in the form of a Biomedical Catalyst competition award.

Immunocore,  Best Biotech Dealmaker

Award Presented by E&Y

Immunocore secured a £142m deal with GSK (July 2013) for ImmTACs to treat cancer and viral disease and a research collaboration and licensing agreement with Genentech (June 2013), valued at up to £300m. The deals come with potential fees and milestone payments which could be worth hundreds of millions according to industry commentators.

Oxford Gene Technology,  Best Medtech Dealmaker

Awar
'/>"/>

SOURCE OBN
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. iLab Solutions to Present at the Midwest Association of Core Directors Annual Meeting
2. Proove Biosciences Continues Its Research Leadership in the Genetics of Pain Medicine at The American Academy of Pain Management’s 24th Annual Meeting
3. Proove Biosciences Will Participate at the California Society of Interventional Pain Physician’s 4th Annual Meeting This Weekend
4. RXi Pharmaceuticals to Present at the 12th Annual BIO Investor Forum
5. Dennis R. Hill, MD to be a Panelist at the Third Annual Prostate Cancer Symposium Focusing on the Changing Paradigm of Prostate Cancer
6. Verenium To Present At The Rodman & Renshaw Annual Global Investment Conference
7. Neuralstem President And CEO To Present At The 2013 Rodman & Renshaw Annual Healthcare Conference
8. Synthetic Biologics to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City
9. Dennis R. Hill, MD to be a Panelist at the Third Annual Prostate Cancer Symposium Focusing on the Changing Paradigm of Prostate Cancer
10. 6th BSMA Annual Executive Summit to Address the Supply Chain Challenges and Solutions of Biopharma
11. Fourth Annual U.S. Symposium at JASIS Organized by Pittcon’s Amit Ghosh and Koichiro Matsuda (Horiba)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Fla. , Dec. 23, 2014  Rock Creek ... that it has filed a Clinical Trial Application (CTA) ... Healthcare products Regulatory Agency (MHRA) seeking regulatory approval to ... lead molecule, Anatabine Citrate. Contingent on the ... conduct a Phase I trial to assess the safety, ...
(Date:12/22/2014)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... development of autologous cell therapies, announced today the publication ... in conjunction with co-authors from Kyoto University and the ... ongoing clinical research using dermal sheath cup (DSC) cells ... The paper entitled " Hair Follicle Dermal Stem Cells ...
(Date:12/22/2014)... The American Journal of Hematology/Oncology, ... and editorials addressing developments and pathways related to ... provocative article exploring the role of follicle-stimulating hormone ... of prostate cancer. , The article references ... that there could be a connection to prostate ...
(Date:12/19/2014)... Charm Sciences is pleased to announce that its ... M1 in raw commingled milk is the first lateral ... peer reviewed report of the validation by Technology and ... Fisheries Research (ILVO-T&V) has been published by the Taylor ... toxic aflatoxin and a known carcinogen, can be passed ...
Breaking Biology Technology:Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2
... (Nasdaq:,SIAL) announced today the global release of ... researchers to reproducibly,interrogate gene function, via siRNA ... not been considered amenable to conventional lipid-based,siRNA ... reagents exhibit a number,of drawbacks, including high ...
... DIEGO, Oct. 18 Volcano Corporation,(Nasdaq: VOLC ) ... shares of its common stock at a price of ... by Volcano. Volcano has granted the,underwriters a 30-day option ... common stock to cover over-allotments, if any. The offering,is ...
... Oct. 17 AMICAS, Inc. (Nasdaq: AMCS ),a ... today announced it will present to and meet with ... being held in New,York. (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ... -- Presentation begins promptly at 10:20 a.m. (Eastern ...
Cached Biology Technology:Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types 2Volcano Corporation Announces Pricing of Common Stock Offering 2
(Date:12/10/2014)... , Dec. 8, 2014 You,ve been here ... account but can,t remember your password, site key or the ... was your first grade teacher? Today, ... the app that will finally put an end to ... 1U TM . 1U leverages a user,s smartphone ...
(Date:12/10/2014)... CIE San Diego has launched an innovative ... tissue that enhances care coordination among social service and ... information; earned a second $1 million grant from the ... aging in community and; will be recognized as a ... 4-6p. CIE San Diego today announced ...
(Date:12/5/2014)... , Dec. 4, 2014 Increased emphasis ... investments in new testing and inspection technologies. The ... rise to a range of innovative test solutions. ... of Generation Y, which is generally more inclined ... result, product development strategies of test equipment vendors ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... CitiusTech announced today that its BI-Clinical platform ... ACO quality measures that are part of the ACO ... BI-Clinical can now help ACO participants assess ... four domains - patient / caregiver experience, care coordination ...
... FLAGSTAFF, Ariz. More peer-reviewed scientific studies of ... and operations are needed to adequately assess their impact, ... literature review conducted by the U.S. Geological Survey and ... their literature review, the authors of the paper, USGS ...
... New findings by Virginie Stevens ( CNRS ), ... Naturelle ) and colleagues show that interactions between dispersal ... study was published as open access paper in the ... dispersal plays a key role in gene flow among ...
Cached Biology News:BI-Clinical Offers 100% Coverage of All ACO Quality Measures Released by CMS 2Literature review on solar energy and wildlife impacts research 2Butterflies: 'Twice-punished' by habitat fragmentation and climate change 2
mIGSF4A Aff Pur PAb...
Human IL-19 MAb (Clone 152112)...
SRY (sex determining region Y)-box 10...
... Steel Staining tray 19 x 29 cm, ... and blot processing.Automated staining of Coomassie Blue ... acid analysis. Prepares blots for high sensitivity ... of protocol, solution, volume, and processing time.Proven ...
Biology Products: